INSIGHTS ON LIQUID DOSE MANUFACTURING
-
Cytiva's Aseptic Filling Workcell User Group
Discover how global collaboration among aseptic filling experts is driving innovation and improving operations.
-
Enhancing Aseptic Fill-Finish Processes
Achieve exceptional product recovery and sterility. Learn about high-integrity surge bags, advanced leak detection, and flexible design options for your fill-finish applications.
-
Low Temperature Storage Containment For Vial And Syringe Systems
With the growth of advanced therapy medicinal products, there is an increased need for specialized low-temperature packaging solutions, particularly for vials and syringe systems at -50°C to ≤ -130°C.
-
CDMO Checklist To Choose The Right Aseptic Isolator
Selecting the right isolator for aseptic filling requires more than comparing features. Discover essential questions to ask and make informed decisions that align with your process and operational goals.
-
CDMO Uses Robotic Gloveless Isolator For Advanced Therapeutics4/28/2025
CDMOs must innovate production architectures to meet the demands of advanced therapeutics to ensure a reliable supply and compliance. Discover how these approaches advance modern medicine and improve patient outcomes.
-
Formulation Development For Therapeutic Oligonucleotides6/10/2025
Discover how expert formulation and analytical support enable the development of stable, injectable oligonucleotide therapies across diverse delivery routes and molecule types.
-
A Risk-Based Decision Framework For Selecting Aseptic Barrier Technologies3/20/2026
EU GMP Annex 1 requires a risk-based approach to selecting Isolators or RABS. This framework evaluates human intervention and decontamination to ensure robust sterility assurance.
-
The Rise In Aseptic Manufacturing Solutions With Smaller Footprints2/19/2025
Aseptic drug manufacturing is going small. Discover how advanced robotic and automated systems with smaller footprints are changing the landscape and boosting accessibility.
-
Contamination Control Of Particulate And Shuttle Blow-Fill-Seal Compliance2/24/2026
Does shuttle blow-fill-seal truly meet Annex 1’s stricter contamination standards? New particle burden data challenges industry assumptions and reveals what manufacturers need to know.
LIQUID DOSE MANUFACTURING SOLUTIONS
-
Open RABS as a housing for aseptic processes, e.g., filling, loading, and unloading of freeze dryers. Product protection is achieved by a barrier (oRABS housing with gloves) between the operator and the product.
-
Cell and gene therapies have increased in popularity in recent years, and thanks to their ability to provide one-time treatments these therapies will play a significant role in treating some of the world's most challenging diseases. These drug products treat patients afflicted with genetic disorders and cancers by targeting the source of disease and altering its genetic makeup to eliminate its cause or symptoms. These therapies are expensive and complex and have been proven effective in numerous cases, but they present a challenge in producing them at scale and at a reasonable cost.
-
Easily integrates into spray drug delivery systems for nasal and sublingual applications. Stevanato Group produces glass microvials from Type I glass.
-
Examine a customizable imaging workstation designed for complex research needs, combining precision engineering, flexible components, and intuitive software to support advanced applications.
-
For highly accurate and controlled filling and weighing of sterile liquids, our proven and reliable technology prevents costly overfilling. The easy to validate aseptic filling machines are compatible with all high-tech production facility equipment, software and processes known in the pharmaceutical primary packaging industry.